Ravi et al. used a liposomal formulation loaded with ferritin heavy chain 1 (FTH1)-targeted siRNAs to treat patient-derived xenograft glioblastoma initiating cells (GIC) (112). This evidence concerns the gene FTH1 and glioblastoma.